For the most part, developing new medical technologies is a huge benefit to people. Take for instance the smart pill that the U.S. Food and Drug Administration (FDA) just approved, which is meant to monitor if patients are sticking to their medication schedule. While incredibly useful, it could also allow entities like the U.S. government to spy on its citizens even more intrusively than it does now.
No one likes to be spied on and yet this is exactly what concerned privacy groups are saying could happen with the digital pill that the FDA just approved for use. Called the Abilify MyCite, the pill comes with sensors that basically indicate if patients just took their medication, Futurism reports.
Abilify is a drug used to treat neurological conditions such as schizophrenia and bipolar disorders. The sensor is embedded in the pill, where it will send out a signal once it comes in contact with the stomach. This signal will be picked up by a patch on the patient’s left rib cage, which will then notify the monitoring personnel via the accompanying app.
The information that the sensors can send out can include the dosage, the exact time when the pill was taken, and even what the patient was doing at the time. Because of how intrusive the data mining process appears, groups concerned about potential abuses are speaking out. They are especially worried about potential punitive actions against patients who are committing what’s called nonadherence.
Basically, nonadherence or noncompliance refers to patients not taking their medication as they are supposed to. This leads to patients getting sicker, which then leads to higher medical costs due to the increased medical attention that they need. Apparently, this particular trend costs $100 billion a year, the New York Times reports.
There’s also the concern of medical professionals that a smart pill could lead to a feeling of coercion on the part of the patients. Subjects could feel pressured to take their medication because their doctors are monitoring them.


Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Google Halts UK YouTube TV Measurement Service After Legal Action
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



